Skip to main content
. 2017 Feb 14;8(1):e02022-16. doi: 10.1128/mBio.02022-16

TABLE 1 .

DG70 MICs in drug-susceptible, drug-resistant, and menG-overexpressing strains of M. tuberculosis and BCGa

Strain and supplement Drug resistance Strain type MIC90 (µg/ml) of drug:
DG70 INH
M. tuberculosis
    H37Rv No Lab 4.8 0.05
    H37Rv + 400 µM MK4 No Lab 9.6 0.05
    210 No Clinical 4.8 0.05
    692 No Clinical 1.2 0.05
    TDR 31 INH, RIF, EMB, KAN, SM, CAP Clinical 1.2 >3.15
    TDR 116 INH, EMB, PAS Clinical 9.6 >3.15
    TDR 36 INH, RIF, EMB Clinical 3.13 >3.15
    TDR 91 RIF, EMB, INH Clinical 4.8 >3.15
    BDQr H37Rv BDQ Clinical 4.8 0.05
    PA824r H37Rv PA824 Lab 4.8 0.05
M. bovis
    BCG No Lab 2.4 0.05
    BCG + 300 µM MK4 ND Lab 9.8 ND
    BCG::pMV306PHsp60 HYG Lab 2.4 ND
    BCG::pMV306PHsp60-menG_Wt HYG Lab 9.8 ND
    BCG::pMV306PHsp60-menG_F118L HYG Lab >40 ND
    BCG::pMV306PHsp60-menG_V20A HYG Lab 20 ND
a

Abbreviations: EMB, ethambutol; RIF, rifampin; INH, isoniazid; KAN, kanamycin; SM, streptomycin; CAP, capreomycin; PAS, para-aminosalicylic acid; BDQ, bedaquiline; HYG, hygromycin B; ND, not determined. MIC90 values were determined by microtiter alamarBlue assay. All MIC90 assays were performed in triplicates.